Patients who received a higher number of MenSCs showed an increasing trend in estradiol levels and a decreasing trend in follicle-stimulating hormone levels.
← all excerpts
Amelioration of female menopausal syndrome by intravenous administration of autologous menstrual blood-derived stem cells.
1
—
—